Agar Market by Product Type (Food Agar, Bacteriological Agar, Pharmaceutical Agar), Grade (Food Grade, Pharmaceutical Grade, Bacteriological Grade), Production Process, Application Area - Global Forecast 2025-2032
Description
The Agar Market was valued at USD 348.02 million in 2024 and is projected to grow to USD 366.75 million in 2025, with a CAGR of 6.73%, reaching USD 586.28 million by 2032.
A context-rich introduction that positions agar as a strategic laboratory medium and industrial ingredient influencing diagnostics development, product innovation, and supply strategy
Agar occupies a central role in many scientific workflows and industrial formulations, serving as both a functional laboratory medium and an ingredient with diverse application value. Its relevance spans from microbial culture systems used in clinical and research settings to texturizing and stabilizing roles in food, pharmaceutical, and cosmetic formulations. The material’s physical properties, supply chain characteristics, and regulatory profile collectively shape how organizations prioritize procurement, quality control, and product development.
In recent years, technological maturation in laboratory automation, increased scrutiny on sustainability, and evolving regulatory expectations have elevated agar from a routine consumable to a strategic input that requires proactive management. Consequently, stakeholders across diagnostics, research, manufacturing, and quality assurance are re-evaluating sourcing strategies, material specifications, and validation protocols. This introduction frames the broader executive summary by identifying core drivers, contextualizing cross-sector dependencies, and setting expectations for the analyses that follow.
How automation, sustainability pressures, evolving regulatory expectations, and next generation diagnostic technologies are jointly redefining agar usage and procurement practices
The landscape for agar use is undergoing transformative shifts driven by multiple converging forces, reshaping demand patterns and operational practices across laboratories and manufacturing facilities. Advances in laboratory automation and high-throughput workflows have changed the way agar is specified and consumed, with an emphasis on consistent lot-to-lot performance and compatibility with robotic handling systems. At the same time, heightened attention to sustainability and traceability has pushed suppliers and buyers to re-examine raw material sourcing and processing methods, prompting innovation around responsible seaweed harvesting and cultivation practices.
Moreover, regulatory evolution and more stringent quality standards in clinical diagnostics and pharmaceutical development have elevated requirements for documentation, raw material testing, and supplier qualification. Parallel progress in molecular diagnostics and alternative culture technologies influences the role agar plays in certain diagnostic pathways, while new applications in formulation science continue to broaden its industrial relevance. Together, these shifts create both risk and opportunity: organizations that adapt procurement, quality assurance, and R&D strategies will strengthen resilience and capture new application-led value.
Evaluating how recent tariff shifts have reshaped agar sourcing, supply chain resilience, and procurement governance across producers and end users
Recent tariff and trade policy actions have exerted a cumulative influence on agar supply chains, prompting manufacturers, distributors, and end users to reassess sourcing geographies and inventory strategies. Tariff-driven cost pressures have increased the visibility of upstream supplier selection, encouraging procurement teams to diversify vendor pools and to place greater emphasis on supplier resilience. In parallel, logistics complexity and customs compliance requirements have amplified the administrative burden associated with cross-border shipments of raw seaweed and processed agar products.
As a result, organizations are increasingly pursuing nearshoring and multi-supplier approaches to mitigate exposure to single-origin disruptions. These strategic responses are accompanied by intensified supplier audits, expanded qualification criteria, and more rigorous traceability measures to preserve product integrity while managing total cost dynamics. In short, tariff developments have accelerated a shift from transactional procurement toward more strategic supply chain governance, with an emphasis on continuity, quality assurance, and regulatory alignment.
Targeted segmentation insights revealing how distinct application contexts in testing, food processing, pharmaceuticals, and cosmetics shape agar requirements and supplier criteria
Segmentation analysis illuminates where agar’s roles differ materially across end uses and technical contexts, enabling more precise prioritization for research, supply chain design, and product development. Based on Microbiological Testing, market study perspectives across Clinical Diagnostics, Pharmaceutical R&D, and Research Laboratories reveal distinct performance and documentation expectations; clinical diagnostics typically require stringent clinical-grade traceability and validated performance, while pharmaceutical R&D and research laboratories prioritize reproducibility and flexibility for method development. Based on Food Industry, consideration of Bakery, Confectionery, and Dairy Products underscores texturizing and stability attributes, where formulators weigh sensory characteristics, process compatibility, and clean-label considerations when selecting gelling agents.
Based on Pharmaceutical, segmentation across Diagnostic Applications, Drug Formulation, and Vaccine Technology highlights divergent regulatory pathways and material handling needs; diagnostic applications emphasize sterility and contamination control, drug formulation demands controlled rheology and excipient compatibility, and vaccine technology stresses stringent quality management and cold-chain considerations for raw materials. Based on Cosmetics, assessment across Hair Care, Personal Care, and Skin Care illustrates the importance of sensory properties, formulation stability, and consumer-driven preferences for natural or sustainably sourced ingredients. Together, these segmentation lenses reveal where performance, regulatory burden, and sustainability criteria intersect to drive procurement and innovation priorities.
Regional dynamics and comparative advantages across the Americas, Europe Middle East and Africa, and Asia Pacific that influence sourcing, compliance, and adoption of agar applications
Regional dynamics play a pivotal role in shaping sourcing strategies, regulatory compliance, and adoption pathways for agar-based products. Across the Americas, demand patterns are influenced by strong activity in clinical diagnostics, growth in specialty food product development, and a regulatory environment that emphasizes supplier qualification and traceability. This region often prioritizes rapid product development cycles and supply continuity, which in turn drives interest in formal supplier partnerships and transparent quality systems.
In Europe, Middle East & Africa, the regulatory landscape places considerable emphasis on harmonized documentation, environmental stewardship, and compliance with regional standards; manufacturers and buyers in this geography frequently engage with certification frameworks and sustainability reporting as they seek to align with evolving consumer and policy expectations. Asia-Pacific is characterized by deep vertical integration in raw seaweed production, extensive downstream processing capacity, and diverse end-market demand. Producers in this region benefit from established cultivation and processing ecosystems, which support a wide range of product qualities and commercial terms. Collectively, these regional contrasts influence logistics planning, supplier selection, and the prioritization of sustainability and quality investments across the agar value chain.
Company level perspectives showing how product quality, supply continuity, technical support, and sustainability commitments drive differentiation and partnership strategies in the agar chain
Company-level dynamics in the agar value chain reflect competing priorities around product differentiation, quality assurance, and sustainability positioning. Leading suppliers are increasingly investing in traceability systems and certification schemes to validate responsible sourcing, with a focus on demonstrating compliance through documentation and third-party verification. At the same time, manufacturers that integrate downstream capabilities-such as customized formulation support, sterile packaging, and application-specific grade development-tend to secure longer-term partnerships with diagnostic and pharmaceutical customers.
Strategic alliances between raw material processors, logistics providers, and application specialists are becoming more common as participants seek to reduce time-to-market and provide integrated value propositions. Investment in manufacturing process control and quality analytics allows companies to reduce variability and meet elevated end-user specifications. From a commercial perspective, differentiation is achieved not only through product quality but also through service offerings such as technical training, method validation support, and supply continuity guarantees that address the operational priorities of laboratory and production customers.
Actionable and prioritized recommendations for leaders to diversify sourcing, strengthen quality systems, embed sustainability, and expand technical service offerings for strategic advantage
Industry leaders should adopt a set of prioritized, actionable steps to strengthen resilience, accelerate innovation, and preserve competitive advantage. First, diversify sourcing strategies to balance geographic risk with quality assurance, and develop secondary supplier relationships that are pre-qualified through rigorous audits and documentation. Second, invest in sustainable raw material practices and supplier development programs that enhance traceability and reduce environmental risks, thereby protecting brand reputation and meeting evolving regulatory expectations.
Third, integrate advanced quality analytics and process controls to reduce variability and support higher-grade applications, while offering customers improved material specifications and validation packages. Fourth, expand technical service offerings including hands-on formulation support and method transfer assistance to deepen customer ties and create stickier commercial relationships. Finally, engage proactively with regulators and standards bodies to shape practical compliance pathways and to anticipate changes that could affect product qualification and documentation requirements. By executing these measures in an aligned and phased manner, organizations can convert emerging risks into strategic advantages.
A rigorous methodology combining primary industry interviews, secondary literature review, supply chain mapping, laboratory validation review, and multi-source triangulation to ensure analytical integrity
The research methodology underpinning this executive summary combined qualitative and quantitative evidence collection with targeted validation to ensure analytical robustness. Primary inputs were obtained through structured interviews with procurement leads, laboratory managers, formulation scientists, and supply chain specialists, which provided first-hand perspectives on operational challenges and supplier expectations. Secondary evidence was gathered from industry publications, regulatory guidance documents, and technical literature to contextualize trends and to validate thematic observations.
Analytical rigor was reinforced through supply chain mapping and vendor capability assessments that identified critical nodes and potential bottlenecks. Laboratory validation practices and technical assessments were reviewed to understand performance differentials across grades and formulations. Finally, findings were triangulated across multiple sources and subjected to editorial and technical review to ensure clarity and accuracy, while limitations were acknowledged where data gaps required cautious interpretation.
A concise concluding synthesis tying together technological progress, regulatory pressures, and supply chain resilience to clarify strategic imperatives for agar stakeholders
In conclusion, the agar landscape is defined by a confluence of technological, regulatory, and commercial forces that are reshaping how organizations source, specify, and apply this versatile material. Advances in laboratory automation and formulation science create new application opportunities but also raise the bar for material consistency and documentation. At the same time, sustainability concerns and trade policy adjustments have heightened the strategic importance of sourcing resilience and supplier transparency.
Stakeholders that respond with diversified supplier networks, enhanced quality systems, and value-added technical services will be better positioned to capture the upside of emerging applications while managing risk. Collaborative engagement across the value chain-between raw material producers, processors, application specialists, and end users-will be essential to standardize practices, accelerate innovation, and sustain growth in a landscape where regulatory expectations and consumer preferences continue to evolve.
Note: PDF & Excel + Online Access - 1 Year
A context-rich introduction that positions agar as a strategic laboratory medium and industrial ingredient influencing diagnostics development, product innovation, and supply strategy
Agar occupies a central role in many scientific workflows and industrial formulations, serving as both a functional laboratory medium and an ingredient with diverse application value. Its relevance spans from microbial culture systems used in clinical and research settings to texturizing and stabilizing roles in food, pharmaceutical, and cosmetic formulations. The material’s physical properties, supply chain characteristics, and regulatory profile collectively shape how organizations prioritize procurement, quality control, and product development.
In recent years, technological maturation in laboratory automation, increased scrutiny on sustainability, and evolving regulatory expectations have elevated agar from a routine consumable to a strategic input that requires proactive management. Consequently, stakeholders across diagnostics, research, manufacturing, and quality assurance are re-evaluating sourcing strategies, material specifications, and validation protocols. This introduction frames the broader executive summary by identifying core drivers, contextualizing cross-sector dependencies, and setting expectations for the analyses that follow.
How automation, sustainability pressures, evolving regulatory expectations, and next generation diagnostic technologies are jointly redefining agar usage and procurement practices
The landscape for agar use is undergoing transformative shifts driven by multiple converging forces, reshaping demand patterns and operational practices across laboratories and manufacturing facilities. Advances in laboratory automation and high-throughput workflows have changed the way agar is specified and consumed, with an emphasis on consistent lot-to-lot performance and compatibility with robotic handling systems. At the same time, heightened attention to sustainability and traceability has pushed suppliers and buyers to re-examine raw material sourcing and processing methods, prompting innovation around responsible seaweed harvesting and cultivation practices.
Moreover, regulatory evolution and more stringent quality standards in clinical diagnostics and pharmaceutical development have elevated requirements for documentation, raw material testing, and supplier qualification. Parallel progress in molecular diagnostics and alternative culture technologies influences the role agar plays in certain diagnostic pathways, while new applications in formulation science continue to broaden its industrial relevance. Together, these shifts create both risk and opportunity: organizations that adapt procurement, quality assurance, and R&D strategies will strengthen resilience and capture new application-led value.
Evaluating how recent tariff shifts have reshaped agar sourcing, supply chain resilience, and procurement governance across producers and end users
Recent tariff and trade policy actions have exerted a cumulative influence on agar supply chains, prompting manufacturers, distributors, and end users to reassess sourcing geographies and inventory strategies. Tariff-driven cost pressures have increased the visibility of upstream supplier selection, encouraging procurement teams to diversify vendor pools and to place greater emphasis on supplier resilience. In parallel, logistics complexity and customs compliance requirements have amplified the administrative burden associated with cross-border shipments of raw seaweed and processed agar products.
As a result, organizations are increasingly pursuing nearshoring and multi-supplier approaches to mitigate exposure to single-origin disruptions. These strategic responses are accompanied by intensified supplier audits, expanded qualification criteria, and more rigorous traceability measures to preserve product integrity while managing total cost dynamics. In short, tariff developments have accelerated a shift from transactional procurement toward more strategic supply chain governance, with an emphasis on continuity, quality assurance, and regulatory alignment.
Targeted segmentation insights revealing how distinct application contexts in testing, food processing, pharmaceuticals, and cosmetics shape agar requirements and supplier criteria
Segmentation analysis illuminates where agar’s roles differ materially across end uses and technical contexts, enabling more precise prioritization for research, supply chain design, and product development. Based on Microbiological Testing, market study perspectives across Clinical Diagnostics, Pharmaceutical R&D, and Research Laboratories reveal distinct performance and documentation expectations; clinical diagnostics typically require stringent clinical-grade traceability and validated performance, while pharmaceutical R&D and research laboratories prioritize reproducibility and flexibility for method development. Based on Food Industry, consideration of Bakery, Confectionery, and Dairy Products underscores texturizing and stability attributes, where formulators weigh sensory characteristics, process compatibility, and clean-label considerations when selecting gelling agents.
Based on Pharmaceutical, segmentation across Diagnostic Applications, Drug Formulation, and Vaccine Technology highlights divergent regulatory pathways and material handling needs; diagnostic applications emphasize sterility and contamination control, drug formulation demands controlled rheology and excipient compatibility, and vaccine technology stresses stringent quality management and cold-chain considerations for raw materials. Based on Cosmetics, assessment across Hair Care, Personal Care, and Skin Care illustrates the importance of sensory properties, formulation stability, and consumer-driven preferences for natural or sustainably sourced ingredients. Together, these segmentation lenses reveal where performance, regulatory burden, and sustainability criteria intersect to drive procurement and innovation priorities.
Regional dynamics and comparative advantages across the Americas, Europe Middle East and Africa, and Asia Pacific that influence sourcing, compliance, and adoption of agar applications
Regional dynamics play a pivotal role in shaping sourcing strategies, regulatory compliance, and adoption pathways for agar-based products. Across the Americas, demand patterns are influenced by strong activity in clinical diagnostics, growth in specialty food product development, and a regulatory environment that emphasizes supplier qualification and traceability. This region often prioritizes rapid product development cycles and supply continuity, which in turn drives interest in formal supplier partnerships and transparent quality systems.
In Europe, Middle East & Africa, the regulatory landscape places considerable emphasis on harmonized documentation, environmental stewardship, and compliance with regional standards; manufacturers and buyers in this geography frequently engage with certification frameworks and sustainability reporting as they seek to align with evolving consumer and policy expectations. Asia-Pacific is characterized by deep vertical integration in raw seaweed production, extensive downstream processing capacity, and diverse end-market demand. Producers in this region benefit from established cultivation and processing ecosystems, which support a wide range of product qualities and commercial terms. Collectively, these regional contrasts influence logistics planning, supplier selection, and the prioritization of sustainability and quality investments across the agar value chain.
Company level perspectives showing how product quality, supply continuity, technical support, and sustainability commitments drive differentiation and partnership strategies in the agar chain
Company-level dynamics in the agar value chain reflect competing priorities around product differentiation, quality assurance, and sustainability positioning. Leading suppliers are increasingly investing in traceability systems and certification schemes to validate responsible sourcing, with a focus on demonstrating compliance through documentation and third-party verification. At the same time, manufacturers that integrate downstream capabilities-such as customized formulation support, sterile packaging, and application-specific grade development-tend to secure longer-term partnerships with diagnostic and pharmaceutical customers.
Strategic alliances between raw material processors, logistics providers, and application specialists are becoming more common as participants seek to reduce time-to-market and provide integrated value propositions. Investment in manufacturing process control and quality analytics allows companies to reduce variability and meet elevated end-user specifications. From a commercial perspective, differentiation is achieved not only through product quality but also through service offerings such as technical training, method validation support, and supply continuity guarantees that address the operational priorities of laboratory and production customers.
Actionable and prioritized recommendations for leaders to diversify sourcing, strengthen quality systems, embed sustainability, and expand technical service offerings for strategic advantage
Industry leaders should adopt a set of prioritized, actionable steps to strengthen resilience, accelerate innovation, and preserve competitive advantage. First, diversify sourcing strategies to balance geographic risk with quality assurance, and develop secondary supplier relationships that are pre-qualified through rigorous audits and documentation. Second, invest in sustainable raw material practices and supplier development programs that enhance traceability and reduce environmental risks, thereby protecting brand reputation and meeting evolving regulatory expectations.
Third, integrate advanced quality analytics and process controls to reduce variability and support higher-grade applications, while offering customers improved material specifications and validation packages. Fourth, expand technical service offerings including hands-on formulation support and method transfer assistance to deepen customer ties and create stickier commercial relationships. Finally, engage proactively with regulators and standards bodies to shape practical compliance pathways and to anticipate changes that could affect product qualification and documentation requirements. By executing these measures in an aligned and phased manner, organizations can convert emerging risks into strategic advantages.
A rigorous methodology combining primary industry interviews, secondary literature review, supply chain mapping, laboratory validation review, and multi-source triangulation to ensure analytical integrity
The research methodology underpinning this executive summary combined qualitative and quantitative evidence collection with targeted validation to ensure analytical robustness. Primary inputs were obtained through structured interviews with procurement leads, laboratory managers, formulation scientists, and supply chain specialists, which provided first-hand perspectives on operational challenges and supplier expectations. Secondary evidence was gathered from industry publications, regulatory guidance documents, and technical literature to contextualize trends and to validate thematic observations.
Analytical rigor was reinforced through supply chain mapping and vendor capability assessments that identified critical nodes and potential bottlenecks. Laboratory validation practices and technical assessments were reviewed to understand performance differentials across grades and formulations. Finally, findings were triangulated across multiple sources and subjected to editorial and technical review to ensure clarity and accuracy, while limitations were acknowledged where data gaps required cautious interpretation.
A concise concluding synthesis tying together technological progress, regulatory pressures, and supply chain resilience to clarify strategic imperatives for agar stakeholders
In conclusion, the agar landscape is defined by a confluence of technological, regulatory, and commercial forces that are reshaping how organizations source, specify, and apply this versatile material. Advances in laboratory automation and formulation science create new application opportunities but also raise the bar for material consistency and documentation. At the same time, sustainability concerns and trade policy adjustments have heightened the strategic importance of sourcing resilience and supplier transparency.
Stakeholders that respond with diversified supplier networks, enhanced quality systems, and value-added technical services will be better positioned to capture the upside of emerging applications while managing risk. Collaborative engagement across the value chain-between raw material producers, processors, application specialists, and end users-will be essential to standardize practices, accelerate innovation, and sustain growth in a landscape where regulatory expectations and consumer preferences continue to evolve.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Surging demand for high-purity agarose in pharmaceutical electrophoresis applications
- 5.2. Expansion of agar use as a plant-based gelling agent in vegan food products
- 5.3. Adoption of sustainable red algae harvesting methods to stabilize agar supply chains
- 5.4. Integration of advanced eco-friendly extraction techniques to enhance agar quality
- 5.5. Rising utilization of agar-based media in rapid microbial pathogen detection assays
- 5.6. Development of low-melting-point agarose for innovative molecular biology protocols
- 5.7. Impact of climate change on seasonal algal yields and agar raw material availability
- 5.8. Growth of Asia-Pacific agar production driven by increased seaweed aquaculture investments
- 5.9. Implementation of blockchain technology to improve traceability in agar distribution networks
- 5.10. Regulatory scrutiny intensifies for agar purity standards in food and pharmaceutical sectors
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Agar Market, by Product Type
- 8.1. Food Agar
- 8.1.1. Standard Food Agar
- 8.1.2. Instant Food Agar
- 8.1.3. Reduced-Calorie Formulations
- 8.2. Bacteriological Agar
- 8.2.1. Dehydrated Culture Media Agar
- 8.2.2. Ready-To-Use Media Agar
- 8.3. Pharmaceutical Agar
- 8.3.1. Excipients
- 8.3.2. Capsules And Tablets
- 8.3.3. Suspension And Syrup Bases
- 8.4. Technical Agar
- 8.4.1. Industrial Applications
- 8.4.2. Textile And Printing
- 8.5. Agarose
- 8.5.1. Standard Agarose
- 8.5.2. Low-Melting Agarose
- 8.5.3. High-Gel-Strength Agarose
- 8.6. Specialty Blends
- 8.6.1. Agar Carrageenan Blends
- 8.6.2. Agar Guar Gum Blends
- 9. Agar Market, by Grade
- 9.1. Food Grade
- 9.2. Pharmaceutical Grade
- 9.3. Bacteriological Grade
- 9.4. Molecular Biology Grade
- 9.5. Technical Grade
- 10. Agar Market, by Production Process
- 10.1. Conventional Extraction
- 10.1.1. Alkaline Treatment
- 10.1.2. Neutral Extraction
- 10.2. Enzyme-Assisted Extraction
- 10.3. Microwave-Assisted Extraction
- 11. Agar Market, by Application Area
- 11.1. Food And Beverage
- 11.1.1. Confectionery And Jelly Products
- 11.1.2. Bakery And Pastry
- 11.1.3. Dairy And Non-Dairy Desserts
- 11.1.4. Meat And Processed Foods
- 11.1.5. Beverages
- 11.2. Microbiology And Biotechnology
- 11.2.1. Culture Media
- 11.2.2. Molecular Biology And Electrophoresis
- 11.2.3. Plant Tissue Culture
- 11.3. Pharmaceuticals And Nutraceuticals
- 11.3.1. Controlled-Release Formulations
- 11.3.2. Capsules And Tablets
- 11.3.3. Dietary Supplements
- 11.4. Personal Care And Cosmetics
- 11.4.1. Skin Care
- 11.4.2. Hair Care
- 11.4.3. Oral Care
- 11.5. Industrial And Household
- 11.5.1. Printing And Textile
- 11.5.2. Paper And Pulp
- 11.5.3. Air Fresheners And Deodorizers
- 12. Agar Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Agar Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Agar Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Able Sales Company, Inc.
- 15.3.2. Acroyali Holdings Qingdao Co. Ltd.
- 15.3.3. AgarGel
- 15.3.4. AGARMEX, S.A. DE C.V.
- 15.3.5. Ashapura Proteins Ltd.
- 15.3.6. Azelis group
- 15.3.7. B&V srl
- 15.3.8. Cape Crystal Brands
- 15.3.9. HISPANAGAR S.A.
- 15.3.10. INDUSTRIAS ROKO S.A.
- 15.3.11. Ingredion Incorporated
- 15.3.12. Java Biocolloid
- 15.3.13. MARINE SCIENCE CO., LTD.
- 15.3.14. Merck KGaA
- 15.3.15. Meron Group
- 15.3.16. MSC Co.,Ltd.
- 15.3.17. Myeongshin Agar Agar Mfg. Co., Ltd.
- 15.3.18. Neogen Corporation
- 15.3.19. New Zealand Manuka Group
- 15.3.20. Norevo GmbH
- 15.3.21. PT SURYA INDOALGAS
- 15.3.22. PT. Agarindo Bogatama
- 15.3.23. Setexam
- 15.3.24. The Bharat Instruments & Chemicals
- 15.3.25. Titan Biotech Limited
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
